Research Calls I
-
Upgrades
- Alkermes (ALKS) upgraded to Outperform from Sector Perform at RBC Capital, tgt $44
- Ciena (CIEN) upgraded to Buy from Neutral at Rosenblatt, tgt $175
- H.B. Fuller (FUL) upgraded to Buy from Neutral at Seaport Research Partners, tgt $80
- InterContinental Hotels Group (IHG) upgraded to Overweight from Underweight at JPMorgan
- Ionis Pharmaceuticals (IONS) upgraded to Neutral from Sell at Goldman, tgt $65
- Kenvue (KVUE) upgraded to Buy from Neutral at Rothschild & Co Redburn, tgt $22
- Macerich (MAC) upgraded to Buy from Neutral at BofA Securities, tgt $23
- One Gas (OGS) upgraded to Outperform from Neutral at Mizuho, tgt $86
- Rapt Therapeutics (RAPT) upgraded to Outperform from Market Perform at Leerink, tgt $37
- Riot Platforms (RIOT) upgraded to Overweight from Neutral at JPMorgan, tgt $19
- Alkermes (ALKS) upgraded to Outperform from Sector Perform at RBC Capital, tgt $44
-
Downgrades
- Apellis Pharmaceuticals (APLS) downgraded to Sell from Neutral at Goldman, tgt $18
- Braskem (BAK) downgraded to Neutral from Buy at UBS, tgt $3.80
- CarMax (KMX) downgraded to In Line from Outperform at Evercore ISI, tgt $52
- CarMax (KMX) downgraded to Perform from Outperform at Oppenheimer
- Civitas Resources (CIVI) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $40
- CleanSpark (CLSK) downgraded to Neutral from Overweight at JPMorgan, tgt $14
- EOG Resources (EOG) downgraded to Sector Perform from Outperform at Scotiabank, tgt $130
- First Merchants (FRME) downgraded to Market Perform from Outperform at Raymond James
- IREN (IREN) downgraded to Underweight from Neutral at JPMorgan, tgt $24
- Warner Bros. Discovery (WBD) downgraded to Sector Weight from Overweight at KeyBanc
- Apellis Pharmaceuticals (APLS) downgraded to Sell from Neutral at Goldman, tgt $18
-
Others
- CRH (CRH) reinstated with a Buy at BofA Securities, tgt $128
- First Horizon (FHN) initiated with a Neutral at DA Davidson, tgt $24
- Kyndryl Holdings (KD) initiated with an Equal Weight at Morgan Stanley, tgt $30
- Materion (MTRN) initiated with a Buy at Freedom Broker, tgt $136
- Methanex (MEOH) initiated with an Outperform at National Bank, tgt $47
- Mirion (MIR) initiated with an Overweight at JPMorgan, tgt $28
- Paycom (PAYC) initiated with a Buy at Guggenheim, tgt $270
- Paylocity (PCTY) initiated with a Neutral at Guggenheim
- Rollins (ROL) initiated with an Overweight at JPMorgan, tgt $70
- Spyre Therapeutics (SYRE) initiated with a Buy at Deutsche Bank, tgt $43
- United Therapeutics (UTHR) initiated with an Outperform at RBC Capital, tgt $569
- Valmont (VMI) initiated with an Overweight at JPMorgan, tgt $480
- CRH (CRH) reinstated with a Buy at BofA Securities, tgt $128